KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash & Current Investments (2016 - 2025)

Astrana Health (ASTH) has disclosed Cash & Current Investments for 16 consecutive years, with $429.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 47.67% to $429.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $429.5 million through Dec 2025, up 47.67% year-over-year, with the annual reading at $429.5 million for FY2025, 47.67% up from the prior year.
  • Cash & Current Investments hit $429.5 million in Q4 2025 for Astrana Health, down from $463.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $463.4 million in Q3 2025 to a low of $217.3 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $313.7 million across 5 years, with a median of $294.9 million in 2022.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 236.9% in 2021 and later plummeted 34.81% in 2022.
  • Year by year, Cash & Current Investments stood at $286.5 million in 2021, then rose by 2.47% to $293.6 million in 2022, then grew by 0.92% to $296.3 million in 2023, then fell by 1.85% to $290.8 million in 2024, then skyrocketed by 47.67% to $429.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for ASTH at $429.5 million in Q4 2025, $463.4 million in Q3 2025, and $342.1 million in Q2 2025.